MMP-9 has been detected in the plasma of patients with carcinomas and has been proposed as a good marker of head and neck SCC.[16] Our data, however, revealed no evidence of a correlation between immunostaining for MMP-9 and the stage of the tumour (Figure 3). Here, MMP9 is linked to neoplasm.